UBS Group’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $158M | Buy |
|
|||||
|
2025
Q2 | $164M | Buy |
|
|||||
|
2025
Q1 | $129M | Sell |
|
|||||
|
2024
Q4 | $115M | Sell |
|
|||||
|
2024
Q3 | $144M | Buy |
|
|||||
|
2024
Q2 | $82.4M | Buy |
|
|||||
|
2024
Q1 | $90.1M | Buy |
|
|||||
|
2023
Q4 | $43.9M | Buy |
|
|||||
|
2023
Q3 | $36.9M | Sell |
|
|||||
|
2023
Q2 | $43.9M | Sell |
|
|||||
|
2023
Q1 | $38.4M | Sell |
|
|||||
|
2022
Q4 | $39.9M | Sell |
|
|||||
|
2022
Q3 | $34.8M | Sell |
|
|||||
|
2022
Q2 | $44.3M | Buy |
|
|||||
|
2022
Q1 | $42.6M | Buy |
|
|||||
|
2021
Q4 | $33.7M | Buy |
|
|||||
|
2021
Q3 | $29.5M | Sell |
|
|||||
|
2021
Q2 | $40.2M | Sell |
|
|||||
|
2021
Q1 | $44M | Sell |
|
|||||
|
2020
Q4 | $39.1M | Sell |
|
|||||
|
2020
Q3 | $37M | Buy |
|
|||||
|
2020
Q2 | $28.5M | Sell |
|
|||||
|
2020
Q1 | $32.4M | Buy |
|
|||||
|
2019
Q4 | $32M | Sell |
|
|||||
|
2019
Q3 | $30.3M | Buy |
|
|||||
|
2019
Q2 | $23.2M | Buy |
|
|||||
|
2019
Q1 | $23.1M | Buy |
|
|||||
|
2018
Q4 | $16.9M | Sell |
|
|||||
|
2018
Q3 | $26.2M | Buy |
|
|||||
|
2018
Q2 | $22.6M | Sell |
|
|||||
|
2018
Q1 | $31.9M | Sell |
|
|||||
|
2017
Q4 | $33.4M | Buy |
|
|||||
|
2017
Q3 | $23M | Buy |
|
|||||
|
2017
Q2 | $24.7M | Sell |
|
|||||
|
2017
Q1 | $43.3M | Buy |
|
|||||
|
2016
Q4 | $27.8M | Buy |
|
|||||
|
2016
Q3 | $26.8M | Sell |
|
|||||
|
2016
Q2 | $35.3M | Sell |
|
|||||
|
2016
Q1 | $47.1M | Sell |
|
|||||
|
2015
Q4 | $58.6M | Buy |
|
|||||
|
2015
Q3 | $35.9M | Buy |
|
|||||
|
2015
Q2 | $36.6M | Sell |
|
|||||
|
2015
Q1 | $47.3M | Sell |
|
|||||
|
2014
Q4 | $43.8M | Buy |
|